Skip to main content

A Phase 1, Open-label, Drug Interaction Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants with Moderate to Severe Crohn's Disease

Clinical Trial Grant
Duke Scholars

Administered By

Duke Clinical Research Institute

Awarded By

Janssen Research & Development, LLC

Start Date

February 12, 2018

End Date

April 10, 2023
 

Administered By

Duke Clinical Research Institute

Awarded By

Janssen Research & Development, LLC

Start Date

February 12, 2018

End Date

April 10, 2023